Atlas

FDA-Inspected Site

Allergan Sales, LLC

15 FDA inspections are on record for Allergan Sales, LLC in Waco, United States.

Clean· No action indicated

Waco, United States · Last updated August 15, 2026

Overview

  • 15 FDA inspections are on record.
  • 6 inspections produced a Form 483.
  • The most recent recorded inspection date is 2022-03-24.

At a glance

Inspections

15

Form 483s

6

EIRs

8

Last outcome

Clean

Inspection history

FDA inspections on record, most recent first.

InspectionCategoryOutcomeForm 483
15 Mar 2022 – 24 Mar 2022Human DrugsClean
29 Jan 2019 – 27 Feb 2019Human Drugs483View 483 →
18 Oct 2016 – 28 Oct 2016Human Drugs483View 483 →
14 Sep 2015 – 8 Oct 2015Human Drugs483On file
22 Jun 2015 – 10 Jul 2015Human Drugs483On file
22 Jul 2013 – 2 Aug 2013Human Drugs483View 483 →
13 Apr 2012Not recordedClean
25 Mar 2011Not recorded483View 483 →
20 Mar 2009Not recordedClean
6 Feb 2009Not recordedClean
21 Feb 2006Not recordedClean
28 Jan 2005Not recordedClean

Observations on record

Form 483 observations cited at this site, most recent first.

27 Feb 2019
21 CFR 211.42(c)(10)(v)

Cleaning System

Cited by Stephen D Brown

27 Feb 2019
21 CFR 211.113(b)

Procedures for sterile drug products

Cited by Stephen D Brown

27 Feb 2019
21 CFR 211.42(c)(10)(iv)

Environmental Monitoring System

Cited by Stephen D Brown

28 Oct 2016
21 CFR 211.110(a)

Control procedures to monitor and validate performance

Cited by Massoud Motamed, Ademola O Daramola

28 Oct 2016
21 CFR 211.110(a)

Control procedures to monitor and validate performance

Cited by Massoud Motamed, Ademola O Daramola

Investigators

FDA investigators tied to this site in the record.

Rebecca Rodriguez3 insp.
Stephen D Brown2 insp.
Massoud Motamed2 insp.
Latorie S Jones2 insp.
Shelby N Turner1 insp.
Suzanne N Vallez1 insp.
Navista C Bolton1 insp.
Ademola O Daramola1 insp.
Shelby N Marler1 insp.
Scott T Ballard1 insp.
Margaret M Annes1 insp.
Darla J Christopher1 insp.
Karen C Daugherty1 insp.
Cntrctmntr J Elkins1 insp.

Recurring citations

CFR citation patterns observed across this site's inspections.

CitationWhat it coversCited
21 CFR 211.113(b)Cited across public-safe Form 483 observations6x
21 CFR 211.192Cited across public-safe Form 483 observations5x
21 CFR 211.42(c)(10)(v)Cited across public-safe Form 483 observations5x
21 CFR 211.110(a)Cited across public-safe Form 483 observations4x
21 CFR 211.111Cited across public-safe Form 483 observations4x
21 CFR 211.160(b)(2)Cited across public-safe Form 483 observations4x
21 CFR 211.194(a)Cited across public-safe Form 483 observations4x
21 CFR 211.194(a)(4)Cited across public-safe Form 483 observations4x
21 CFR 211.68(a)Cited across public-safe Form 483 observations4x
21 CFR 211.42(c)(10)(iv)Cited across public-safe Form 483 observations2x
21 CFR 211.165(a)Cited across public-safe Form 483 observations1x
21 CFR 211.22(d)Cited across public-safe Form 483 observations1x
21 CFR 211.28(a)Cited across public-safe Form 483 observations1x
21 CFR 211.42(c)(10)(i)Cited across public-safe Form 483 observations1x
21 CFR 211.56(b)Cited across public-safe Form 483 observations1x
21 CFR 211.63Cited across public-safe Form 483 observations1x

Full site report

Get the verbatim findings behind Allergan Sales, LLC's 6 Form 483s

Source PDFs, verbatim observations, and recurring CFR citations, so your team knows what this site gets cited for.

  • The site's full inspection history, with every Form 483 and its outcome
  • Warning letters and recalls tied to the company behind it
  • Whether recurring CFR citations get closed out or repeat